Tag: preclinical cancer research

Researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy have identified a potential way ...

A new preclinical study reports that a previously underexplored biguanide-based compound, 4C, can dramatically enhance the anticancer effects of talazoparib ...

Pancreatic cancer is notoriously resistant to immunotherapy because many tumors develop an immune-suppressive, oxygen-poor “cold” microenvironment that blocks effective T ...

In a groundbreaking advancement poised to reshape the future of oncological therapeutics, researchers at Weill Cornell Medicine have engineered a ...

Philadelphia-based researchers at the University of Pennsylvania’s Perelman School of Medicine are pioneering a transformative approach to treating one of ...

In a groundbreaking study poised to redefine the frontiers of cancer therapy, researchers have demonstrated the extraordinary potential of Boron ...

In a landmark advancement for oncology, a collaborative research team from the Medical University of Vienna, the HUN-REN Research Centre ...

In a groundbreaking advancement that could reshape the future of brain cancer therapy, researchers have unveiled a novel immunotherapeutic strategy ...

In a groundbreaking development in the field of cancer treatment, researchers at the Massachusetts Institute of Technology (MIT) have unveiled ...

In a groundbreaking study that has the potential to reshape the treatment landscape for pancreatic cancer, researchers from the Perelman ...